Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 798 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Diagnosed Alone October 6, 2020 Elderly Woman Seeks Trick-Or-Treaters Who Surprised Her With Gifts The Day... November 12, 2021 Multiple mRNA Vaccines Show Promise for Treating HPV-Related Cancers April 26, 2023 Foodie Fridays-Gazpacho: A Favorite Summer Soup August 6, 2021 Load more HOT NEWS Black Patients Are More Likely to Die of Cancer—Here’s How One... How Running and Training for a Marathon Helped Me Cope After... Addressing Common Concerns Around Taking Opioids for Cancer-Related Pain: An Expert... FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes
